Eiger BioPharmaceuticals, Inc. 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Apr 13, 2017
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-04-12+10,000→ 10,000 totalExercise: $8.50Exp: 2027-04-12→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 12 months measured from April 12, 2017 subject to Reporting Person's continuous service status as of each such date.